Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure.

Srinivasan A, Patel JB.

Infect Control Hosp Epidemiol. 2008 Dec;29(12):1107-9. doi: 10.1086/594129. No abstract available.

PMID:
18973453
2.

Regional dissemination of KPC-producing Klebsiella pneumoniae.

Kitchel B, Sundin DR, Patel JB.

Antimicrob Agents Chemother. 2009 Oct;53(10):4511-3. doi: 10.1128/AAC.00784-09. Epub 2009 Aug 17.

3.

High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China.

Chen S, Hu F, Xu X, Liu Y, Wu W, Zhu D, Wang H.

Antimicrob Agents Chemother. 2011 May;55(5):2493-4. doi: 10.1128/AAC.00047-11. Epub 2011 Feb 14. No abstract available.

4.

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Nordmann P, Cuzon G, Naas T.

Lancet Infect Dis. 2009 Apr;9(4):228-36. doi: 10.1016/S1473-3099(09)70054-4. Review.

PMID:
19324295
5.

Klebsiella pneumoniae Carbapenemase-2, Buenos Aires, Argentina.

Pasteran FG, Otaegui L, Guerriero L, Radice G, Maggiora R, Rapoport M, Faccone D, Di Martino A, Galas M.

Emerg Infect Dis. 2008 Jul;14(7):1178-80. doi: 10.3201/eid1407.070826. No abstract available.

6.

Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.

Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y.

Antimicrob Agents Chemother. 2007 Aug;51(8):3026-9. Epub 2007 Jun 11.

7.

Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae.

Potron A, Nordmann P, Lafeuille E, Al Maskari Z, Al Rashdi F, Poirel L.

Antimicrob Agents Chemother. 2011 Oct;55(10):4896-9. doi: 10.1128/AAC.00481-11. Epub 2011 Jul 18.

8.

Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae.

Gomez S, Pasteran F, Faccone D, Bettiol M, Veliz O, De Belder D, Rapoport M, Gatti B, Petroni A, Corso A.

Clin Microbiol Infect. 2013 May;19(5):E233-5. doi: 10.1111/1469-0691.12142. Epub 2013 Feb 12.

9.

A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy.

Ambretti S, Gaibani P, Caroli F, Miragliotta L, Sambri V.

New Microbiol. 2010 Jul;33(3):281-2.

10.

First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.

Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP; Colombian Nosocomial Resistance Study Group..

Antimicrob Agents Chemother. 2006 Aug;50(8):2880-2.

11.

Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital.

Zhang R, Wang XD, Cai JC, Zhou HW, Lv HX, Hu QF, Chen GX.

J Med Microbiol. 2011 Jul;60(Pt 7):977-82. doi: 10.1099/jmm.0.015826-0. Epub 2011 Mar 10.

PMID:
21393450
12.

Klebsiella pneumoniae Carbapenemase-producing Enterobacteriaceae, Northeast Florida.

Halstead DC, Sellen TJ, Adams-Haduch JM, Dossenback DA, Abid J, Doi Y, Paterson DL.

South Med J. 2009 Jul;102(7):680-7. doi: 10.1097/SMJ.0b013e3181a93f9e.

PMID:
19487990
13.

Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010.

Gaibani P, Ambretti S, Berlingeri A, Gelsomino F, Bielli A, Landini MP, Sambri V.

Euro Surveill. 2011 Feb 24;16(8). pii: 19800.

14.

Emergence of Klebsiella pneumoniae carbapenemase-producing Proteus mirabilis in Hangzhou, China.

Sheng ZK, Li JJ, Sheng GP, Sheng JF, Li LJ.

Chin Med J (Engl). 2010 Sep;123(18):2568-70.

PMID:
21034629
15.

Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Calfee DP.

J Infus Nurs. 2010 May-Jun;33(3):150-4. doi: 10.1097/NAN.0b013e3181d9c5ab.

PMID:
20442598
16.

National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.

Chiu SK, Wu TL, Chuang YC, Lin JC, Fung CP, Lu PL, Wang JT, Wang LS, Siu LK, Yeh KM.

PLoS One. 2013 Jul 24;8(7):e69428. doi: 10.1371/journal.pone.0069428. Print 2013.

17.

Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.

Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S; Network EuSCAPE-Italy., Grundmann H, Pantosti A, Rossolini GM.

Euro Surveill. 2014 Oct 23;19(42). pii: 20939.

18.

Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.

Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, Tsioka A, Roilides E, Sofianou D, Gritsi-Gerogianni N.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1250-6. doi: 10.1086/657135. Epub 2010 Oct 25.

PMID:
20973725
19.

First report of KPC-2 Carbapenemase-producing Klebsiella pneumoniae in Japan.

Saito R, Takahashi R, Sawabe E, Koyano S, Takahashi Y, Shima M, Ushizawa H, Fujie T, Tosaka N, Kato Y, Moriya K, Tohda S, Tojo N, Koike R, Kubota T.

Antimicrob Agents Chemother. 2014 May;58(5):2961-3. doi: 10.1128/AAC.02072-13. Epub 2014 Feb 24.

20.

Surveillance and characterization of carbapenemase-producing Klebsiella pneumoniae recovered from patient stool samples at a tertiary care medical center.

Mollenkopf DF, Faubel RL, Pancholi P, Landers TF, Erdman MM, Daniels JB, Wittum TE.

Antimicrob Agents Chemother. 2015 Sep;59(9):5857-9. doi: 10.1128/AAC.01085-15. Epub 2015 Jun 22. No abstract available.

Supplemental Content

Support Center